NKX3-1 and posterior cortical atrophy: We demonstrate our approach in PCa defined by the loss of NKX3-1 or RB1 and make ProstaMine publicly accessible to evaluate user-defined subtypes through a user-friendly R Shiny application (https://bioinformatics.cuanschutz.edu/prostamine).